You are here: Industry Insights > GMP

News List

Northwest Bio Seeks GMP Certification of Sawston Mfg. Facility contractpharma
May 13, 2021
Northwest Biotherapeutics, a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, applied for certification of the manufacturing facility in Sawston, UK with the Medicines and Healthcare Products Regulatory ...
NJ Bio Moves Headquarters to Princeton, New Jersey contractpharma
May 12, 2021
NJ Biopharmaceuticals (NJ Bio), a provider of chemistry and biopharmaceutical services specializing in bioconjugation, custom synthesis, flow chemistry, and process development, has moved its headquarters from North Brunswick to Princeton, NJ.
AMRI Adds R&D and Mfg. Solutions for Orphan Products contractpharma
May 06, 2021
Albany Molecular Research, Inc. (AMRI), a global provider of contract research, development and manufacturing services, expanded access to its accelerated solutions platform, spanning R&D to manufacturing for orphan and rare disease products.
NuvOx Completes Construction of Expanded Manufacturing Facility contractpharma
May 06, 2021
NuvOx Pharma has completed construction and initiated operation of its GMP production facility for manufacturing its injectable pharmaceutical products at its Tucson, AZ facility.
PPD to Expand GMP Lab in Ireland contractpharma
April 30, 2021
PPD, Inc., a global contract research organization (CRO), is expanding its Athlone, Ireland, GMP laboratory, increasing the size of its current facility and adding cell and gene therapy testing to the operation’s portfolio of services.
Aceto Acquires A&C contractpharma
April 28, 2021
Aceto, a global provider of specialty materials for life sciences and advanced technology end markets, has acquired A&C, a global GMP (Good Manufacturing Practices) manufacturer of specialty excipients, buffers, and process solutions.
Further woes for Emergent’s Bayview vaccine production facility europeanpharmaceuticalreview
April 26, 2021
An FDA inspection identified nine concerns including unsanitary conditions and ineffective practices for preventing cross-contamination at Emergent’s facility.
Pharmaceutical sterility testing market to value over $1000 million by 2027 europeanpharmaceuticalreview
April 21, 2021
Reports suggest the global sterility testing market will grow because of the expansion of pharma and biopharma, increasing R&D activities and the launch of new products.
Abenza Chooses North Carolina for New Biologics Manufacturing Site contractpharma
April 16, 2021
Abzena, a global partner research organization (PRO) specializing in the integrated development and manufacture of complex biologics and bioconjugates, has said that the location of its new GMP manufacturing facility will be Sanford, NC.
Biocon Pharma gets GMP compliance certificate from MHRA, UK expresspharma
April 13, 2021
Biocon Pharma, a wholly-owned subsidiary of Biocon, has received a certificate of Good Manufacturing Practice (GMP) compliance from the Medicines & Healthcare products Regulatory Agency (MHRA), the United Kingdom (UK), for its manufacturing facility ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 15 16 Next page